Results for the substance capivasertib

Capivasertib is an investigational drug used in the treatment of certain types of cancer, including triple-negative breast cancer and other solid tumors. It is an AKT kinase inhibitor, which plays a critical role in cancer cell growth and survival.

By blocking AKT activity, capivasertib can slow or stop tumor growth and enhance the effectiveness of other anticancer therapies. It is often used in combination with other drugs, such as hormone receptor inhibitors or chemotherapeutics.

The medication is administered orally, usually in cycles, as directed by a doctor. Patients need to be closely monitored to assess their response to treatment and manage potential side effects.

Side effects may include nausea, diarrhea, fatigue, skin rashes, and changes in blood sugar levels. It is important for patients to inform their doctor of any unusual symptoms or adverse reactions.